| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4180fc57a693864e2ce2dbfd64a9278 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4409 |
| filingDate |
2001-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0f30efbf0d6d3356eb0ab74bb13572d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d056e72300aa5410c961dce05a27f4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6873a7d5f1a9dc0f2fa6aebdae9e92cf |
| publicationDate |
2007-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BG-109953-A |
| titleOfInvention |
Use of r(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorphenyl)ethyl]-4-piperidinemethanol for the treatment of sleep disorders |
| abstract |
The invention relates to the use of R(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorphenyl)ethyl]-4-piperidinemethanol or a pharmaceutically acceptable salt thereof for the production of a medicine for the treatment of sleep disorders, as well as to the use of the compound or a pharmaceutically acceptable salt thereof for the production of a medicine for treatment of sleep disorder or some other condition that may be treated with the said R(+)-alpha-compound or a pharmaceutically acceptable salt thereof. |
| priorityDate |
1998-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |